Yesterday, Nov. 17, 2015, 80 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $220.10 to $2,203,162.50.

Highlighted Stocks Traded by Insiders:

Middleby (MIDD) - FREE Research Report

Putnam Philip G, who is Director at Middleby, sold 800 shares at $103.19 on Nov. 17, 2015. Following this transaction, the Director owned 13,100 shares meaning that the stake was reduced by 5.76% with the 800-share transaction.

The shares most recently traded at $104.56, up $1.37, or 1.31% since the insider transaction. Historical insider transactions for Middleby go as follows:

  • 4-Week # shares sold: 1,400
  • 12-Week # shares sold: 1,400
  • 24-Week # shares sold: 1,400

The average volume for Middleby has been 384,500 shares per day over the past 30 days. Middleby has a market cap of $6.0 billion and is part of the industrial goods sector and industrial industry. Shares are up 3.58% year-to-date as of the close of trading on Tuesday.

The Middleby Corporation designs, manufactures, markets, distributes, and services commercial foodservice and food processing, and residential kitchen equipment in the United States, Canada, Asia, Europe, the Middle East, and Latin America. The company has a P/E ratio of 30.7. Currently, there are 3 analysts who rate Middleby a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MIDD - FREE

TheStreet Quant Ratings

rates Middleby as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Middleby Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Watts Water Technologies (WTS) - FREE Research Report

Melhem Elie, who is President, Asia at Watts Water Technologies, sold 1,200 shares at $53.70 on Nov. 17, 2015. Following this transaction, the President, Asia owned 23,735 shares meaning that the stake was reduced by 4.81% with the 1,200-share transaction.

The shares most recently traded at $54.04, up $0.34, or 0.63% since the insider transaction. Historical insider transactions for Watts Water Technologies go as follows:

  • 4-Week # shares sold: 8,653
  • 12-Week # shares sold: 9,865
  • 24-Week # shares sold: 16,535

The average volume for Watts Water Technologies has been 192,100 shares per day over the past 30 days. Watts Water Technologies has a market cap of $1.5 billion and is part of the industrial goods sector and industrial industry. Shares are down 15.57% year-to-date as of the close of trading on Tuesday.

Watts Water Technologies, Inc. designs, manufactures, and sells water safety and flow control products in the Americas and Europe, Middle East and Africa, and Asia-Pacific. The stock currently has a dividend yield of 1.26%. Currently, there are 6 analysts who rate Watts Water Technologies a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WTS - FREE

TheStreet Quant Ratings

rates Watts Water Technologies as a

hold

. The company's strengths can be seen in multiple areas, such as its expanding profit margins and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full

Watts Water Technologies Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Boston Scientific (BSX) - FREE Research Report

Mario Ernest, who is Director at Boston Scientific, sold 125,000 shares at $17.63 on Nov. 17, 2015. Following this transaction, the Director owned 86,032 shares meaning that the stake was reduced by 59.23% with the 125,000-share transaction.

The shares most recently traded at $17.56, down $0.07, or 0.37% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares bought: 11,700
  • 4-Week # shares sold: 63,279
  • 12-Week # shares bought: 11,700
  • 12-Week # shares sold: 66,779
  • 24-Week # shares bought: 11,700
  • 24-Week # shares sold: 87,648

The average volume for Boston Scientific has been 9.6 million shares per day over the past 30 days. Boston Scientific has a market cap of $23.9 billion and is part of the health care sector and health services industry. Shares are up 32.68% year-to-date as of the close of trading on Tuesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. Currently, there are 14 analysts who rate Boston Scientific a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings

rates Boston Scientific as a

hold

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full

Boston Scientific Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.